Stocks to Buy: 3 Undiscovered Giants Poised for Unexpected Gains

Stocks to buy

Finding untapped opportunities in the volatile world of stock trading may lead to substantial financial advantages. Three businesses stand out in the crowded market as attractive investments for those looking for unrealized potential. These businesses are noteworthy for their unique advantages and astute moves, making them appealing options for investors seeking to expand their holdings.

The first one stands out for having an amazing revenue growth rate of over 100%. This demonstrates its skill at gaining market share and broadening its range of products. The second one, however, uses its niche market. This substantially contributes to company revenue and demonstrates its capacity to precisely and effectively serve niche markets. By increasing its capacity to meet rising demand, the firm strengthens its position and demonstrates a proactive commitment to seizing market possibilities.

Lastly, the third has a strong performance and a favorable growth prognosis. With the anticipated double-digit revenue growth, the firm’s management has expressed confidence in its capacity to maintain momentum and capitalize on developing industry trends.

ACM Research (ACMR)

Source: Pavel Kapysh / Shutterstock.com

In Q1 2024, ACM Research (NASDAQ:ACMR) had a massive 105% increase in sales over Q1 2023. This expansion demonstrates the company’s fundamental capacity to gain market share and increase its clientele. The company’s income sources are spread among several product areas, such as advanced packaging, single-wafer cleaning, and other technologies. Indeed, this diversity improves overall revenue stability by lowering reliance on any one product sector.

Additionally, despite minor changes, ACM Research exceeded the projected range of 40% to 45% by maintaining a gross margin of 52.5% in the first quarter of 2024, suggesting effective pricing and cost-control techniques. ACM Research’s operating margin was 26.2%, a considerable increase from 14.7% during the same time last year. Indeed, this expansion demonstrates the company’s capacity to convert sales growth into increased profitability.

Moreover, ACM Research claims to support around 90% of all cleaning process SAPS for memory and logic devices, making it the most complete cleaning portfolio in the market. Finally, the technological qualities of the company’s main products, such as the Tahoe and TEBO single-wafer cleaning solutions, are unrivaled by rivals. 

United Microelectronics (UMC)

Source: Ascannio via shutterstock

United Microelectronics’ (NYSE:UMC) specialist division generated 57% of total sales in Q1 2024. This was fueled by the need for silicon interposers for AI servers, radio-frequency silicon-on-insulator chips, and power management ICs. Thus, this diversity shows that United Microelectronics can serve niche markets and is less reliant on a single product line.

Moreover, United Microelectronics has demonstrated its focus on advancement and flexibility. This is done by responding to emerging industry trends by concentrating on major pipeline projects. These include tailored solutions and new technology platforms for high-growth categories, including 5G, artificial intelligence of things, and automotive industries.

Additionally, in Q1, United Microelectronics saw a rise in its 12-inch equivalent capacity, hitting 1.2 million. UMC’s deliberate investment in capacity to satisfy rising demand and seize market opportunities is reflected in this growth. CapEx for United Microelectronics in 2024 amounted to around NT$3.3 billion, mostly for the growth of its 12-inch capacity. Therefore, this steady investment approach supports future development plans and guarantees the continuation of capacity expansion activities.

Ceragon (CRNT)

Source: Pavel Kapysh / Shutterstock.com

Ceragon (NASDAQ:CRNT) delivered a non-GAAP net income of $4.7 million, or $0.05 per diluted share, in Q1 2024. This is a solid boost against $3.6 million, or $0.04 per diluted share, in Q1 2023. Fundamentally, valuation gains come from increased profits per share as Ceragon’s top and bottom lines expand.

Moreover, with inventories down from $68.8 million in December 2023 to $61 million at the end of Q1, Ceragon could retain a cash position of $28.8 million. The solid cash position guarantees flexibility and stability in the company’s upcoming operations and investments. The decrease in inventory levels is a result of sharp inventory management techniques. Hence, they maximized the working capital edge and matched inventory levels to variations in demand.

Further, Ceragon restated its forecast for 2024, estimating a top-line of $385 million to $405 million, or an 11% to 17% boost from 2023. Management has a solid stance on Ceragon’s fundamental capacity to maintain pace and edge on market demand. The outlook reaffirmation demonstrates this. Overall, together with operating margin targets of at least 10%, the anticipated rise in sales demonstrates Ceragon’s focus on promoting top-line and bottom-line growth.

As of this writing, Yiannis Zourmpanos held a long position in ACMR. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.

Articles You May Like

Autonomous Vehicles: Why 2025 Will Usher in the Self-Driving Car
Dental supply stock rallies on theory RFK’s anti-fluoride stance will prompt more dentist visits